On Wednesday, Cushman & Wakefield reached an important technical milestone, with its Relative Strength (RS) Rating rising into the 90-plus percentile with an improvement to 93, up from 87 the day before.
IBD's proprietary rating identifies price movement with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the last 52 weeks stacks up against all the other stocks in our database.
History shows that the stocks that go on to make the biggest gains tend to have an 80 or better RS Rating at the beginning of a new climb.
How To Use Stock Charts To Stay Profitable And Protected
Cushman & Wakefield has moved more than 5% past a 13.99 entry in a first-stage flat base, meaning it's now out of a proper buy zone. Look for the stock to offer a new chance to get in like a three-weeks tight or pullback to the 50-day or 10-week line.
The company saw both earnings and sales growth rise last quarter. Earnings-per-share increased from -9% to 10%. Revenue rose from -5% to 3%.
The company holds the No. 13 rank among its peers in the Real Estate-Development/Operations industry group. Amrep Corp, CBRE Group and FirstService are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
